![[VayaVision in Globe Newswire] LeddarTech Acquires VayaVision to Accelerate the Delivery of its Comprehensive and Open Sensor Fusion and Perception Platform for the Automotive and Mobility Market](https://blog.ourcrowd.com/wp-content/uploads/2019/09/Globe-Newswire-new.jpg)
LeddarTech®, a leader in ADAS and AD technology, is pleased to announce the acquisition of sensor fusion and perception software company VayaVision.
Read more here.
[VayaVision in Globes] LeddarTech buys Israeli car sensor co VayaVision
![[VayaVision in Globes] LeddarTech buys Israeli car sensor co VayaVision](https://blog.ourcrowd.com/wp-content/uploads/2017/10/Globes-NEW.jpg)
VayaVision applies AI and computer vision algorithms to raw data fused from radar, lidar and camera to build an accurate 3D environmental model.
Read more here.
[VayaVision in CTech] Israeli autonomous vehicle startup VayaVision acquired by Canada’s LeddarTech
![[VayaVision in CTech] Israeli autonomous vehicle startup VayaVision acquired by Canada’s LeddarTech](https://blog.ourcrowd.com/wp-content/uploads/2019/01/ctech-NEW.jpg)
Canadian company LeddarTech Inc. announced Tuesday it has acquired Israeli automotive company VayaVision Sensing Ltd.
Read more here.
[Syqe in Interesting Engineering] Microdoses of Cannabis Relieve Chronic Pain, Shows First-Ever Clinical Trial
![[Syqe in Interesting Engineering] Microdoses of Cannabis Relieve Chronic Pain, Shows First-Ever Clinical Trial](https://blog.ourcrowd.com/wp-content/uploads/2018/06/interesting-engineering.jpg)
The results of Syqe Medical’s small clinical trial suggest that when taken in small doses, THC minimizes chronic pain without inducing any psychoactive side effects.
Read more here.
[Lemonade in Market Watch] Lemonade stock squeezes out a second day of huge post-IPO gains
![[Lemonade in Market Watch] Lemonade stock squeezes out a second day of huge post-IPO gains](https://blog.ourcrowd.com/wp-content/uploads/2020/04/MarketWatch.png)
Lemonade Inc. LMND, +16.97% shares had a second strong day of trading Monday following the mobile-based insurance startup launched its initial public offering late Wednesday. Lemonade shares recently touched an intraday high of $96.51 and were last up 31% at $91.17.
Read more here.
[OurCrowd CEO Jon Medved in Newsweek] Can the ‘Start-up Nation’ Bounce Back from COVID-19? | Opinion
![[OurCrowd CEO Jon Medved in Newsweek] Can the ‘Start-up Nation’ Bounce Back from COVID-19? | Opinion](https://blog.ourcrowd.com/wp-content/uploads/2018/03/newsweek.jpg)
“COVID-19 has brought clarity to signal to noise – If a company is growing now, that is interesting, it is an inflection point,” Medved said. He believes, “Digital transformation will affect Israel positively.”
Read more here.
[Zoomcar in Your Story] How Zoomcar wooed Sequoia Capital to invest in the team
![[Zoomcar in Your Story] How Zoomcar wooed Sequoia Capital to invest in the team](https://blog.ourcrowd.com/wp-content/uploads/2018/02/your-story-logo.png){kind=logo}
Looking to raise your first round of funding? But do not know what works and what doesn’t? Here are some stories on how startups were able to clinch the deal and what steps they believe founders should take during fundraising. This time we cover Zoomcar.
Read more here.
[Lemonade in TechCrunch] Startups Weekly: Tech unicorns look to IPOs as Lemonade, Accolade boom
![[Lemonade in TechCrunch] Startups Weekly: Tech unicorns look to IPOs as Lemonade, Accolade boom](https://blog.ourcrowd.com/wp-content/uploads/2017/09/Techcrunch.jpg)
Lemonade is being valued at more than 15x the value of its annualized Q1 revenue despite not sporting the gross margins you might expect investors to demand for it to merit that SaaS valuation. And Accolade only expects to grow by about 20% in Q2 2020 compared to its year-ago results while probably losing more money.
Read more here.
- 1
- 2
- 3
- …
- 660
- Next Page »